STREPSILS LOZENGE is a brand name for Amylmetacresol. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: For the symptomatic relief of mouth and throat infections.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Use the lowest dose for the shortest duration necessary to relieve symptoms. Adults One lozenge every 2-3 hours up to a maximum of 12 lozenges in 24 hours.
Elderly:
There is no need for dosage reduction in the elderly.
Children over 6 years old:
As above for adults.
Children under 6 years old:
Not suitable for children under 6 years. 4). Method of Administration For oral administration. To be dissolved slowly in the mouth.
The list of the following adverse effects relates to those experienced with 2,4- dichlorobenzyl alcohol and amylmetacresol at OTC doses, in short term use. Adverse events which have been associated with 2,4-dichlorobenzyl alcohol and amylmetacresol are given below, tabulated by system organ class and frequency.
Frequencies are defined as:
Very common (≥1/10); Common (≥1/100 and <1/10); Uncommon (≥1/1000 and <1/100); Rare (≥1/10,000 and <1/1000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). Within each frequency grouping, adverse events are presented in order of decreasing seriousness.
System Organ Class Frequency Adverse Events Immune System Disorders Not known Hypersensitivityab1 Gastrointestinal Disorders Not known Glossodyniaab, oral discomfortab a2,4-dichlorobenzyl alcohol bamylmetacresol 1 Hypersensitivity reactions may include rash, urticaria and angioedema, which may include swelling of the face, neck, throat or tongue that could affect breathing.
Reporting of Suspected Adverse Reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Not to be given to children under 6 years. If symptoms persist, have not improved, or have worsened after 3 days, consult a doctor or health care professional. 013 g glucose per lozenge. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine.
This medicine contains only very low levels of gluten (from wheat starch). It is regarded as ‘gluten-free’ and is very unlikely to cause problems if you have coeliac disease. 26 micrograms of gluten. If you have wheat allergy (different from coeliac disease) you should not take this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’. This medicine contains Carmoisine (E122) and Ponceau 4R (E124) which may cause allergic reactions. This medicine contains sulphites – Sulphur dioxide (E220) which may rarely cause severe hypersensitivity reactions and bronchospasm.
This medicine contains fragrance with Anisyl Alcohol, d-Limonene and Linalool, which may cause allergic reactions.
Hypersensitivity to any of the ingredients.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Amylmetacresol in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.